For instance, Liu Y et al. demonstrated that MRPL13 can be treated as a prognostic molecular marker that can promote the growth, division, metastasis and invasion of breast cancer cells as a catalyst and ultimately lead to poor prognosis of patients. Here, MRPL13 is linked to breast carcinoma.